Excluding Epidemiological Evidence Under FRE 702 in Toxic Tort, Medical Device, and Pharmaceutical Cases
Strategies for Exposing an Expert's Serious Methodological Deficiencies
Recording of a 90-minute CLE video webinar with Q&A
This CLE webinar will discuss the admissibility of epidemiological evidence in toxic tort, medical device, and pharmaceutical product liability cases. The panel will review the proper role of epidemiology in showing general causation and how to challenge studies and experts under Federal Rule of Evidence 702 and Daubert.
- General, specific, and legal causation
- Role of differential diagnosis
- Science of epidemiology and the hierarchy of evidence
- Association vs. causation
- Bradford Hill criteria
- International Agency for Research on Cancer (IARC)
- Assessing admissibility under FRE 702
- Assist trier of fact
- Sufficient facts or data
- Product of reliable principles and methods
- Expert has reliably applied the principles and methods to the facts of the case
- Daubert criteria for scientific evidence
- Strategies for plaintiffs and defendants
The panel will discuss these and other key issues:
- What is epidemiology?
- Can epidemiological studies support specific causation?
- When considering admissibility, does rebuttal expert evidence have to meet the same standards as the plaintiff's evidence?
- What factors show that an expert's opinion does not reflect a reliable application of the principles and methods to the facts of the case?
Christopher G. Campbell
Mr. Campbell is a partner in the firm’s Product Liability and Mass Tort practice. He has experience in all phases... | Read More
Mr. Campbell is a partner in the firm’s Product Liability and Mass Tort practice. He has experience in all phases of litigation, including first-chairing jury and bench trials in state and federal courts and arguing appeals. He is co-author of the book Expert Witnesses: Products Liability Cases (West 2009), an in-depth guide to expert witness development in all types of product liability and mass tort matters, including pharmaceutical, toxic torts, automotive, industrial accidents and children's and consumer products.Close
Stephen J. McConnell
Mr. McConnell defends clients in product liability and mass tort litigation. He has also handled securities litigation,... | Read More
Mr. McConnell defends clients in product liability and mass tort litigation. He has also handled securities litigation, complex commercial litigation, and white-collar criminal litigation. He is a former Assistant U.S. Attorney with ample first-chair experience in both government and private practice cases and has successfully argued significant matters before federal and state trial and appellate courts. Mr. McConnell has represented consumer products manufacturers and leading global medical device and pharmaceutical companies, including Wyeth, for whom he served as first-chair trial counsel in the diet drug litigation.Close
Ms. Carrier is a litigation lawyer with experience in government, law firm, and corporate legal department roles. Her... | Read More
Ms. Carrier is a litigation lawyer with experience in government, law firm, and corporate legal department roles. Her practice focuses on defending international corporations in complex litigation, primarily in the consumer products, pharmaceutical, and women's health sectors. Ms. Carrier's experience arguing before state, federal, and bankruptcy courts help her guide companies in all phases of case management and trial preparation. She also advises clients in a wide variety of non-dispute matters, including product development and compliance.Close
Christian W. Castile
Mr. Castile is a trial attorney in Reed Smith’s Philadelphia office. His practice involves a wide range of... | Read More
Mr. Castile is a trial attorney in Reed Smith’s Philadelphia office. His practice involves a wide range of commercial litigation matters, with a focus on defending pharmaceutical and medical device manufacturers in products liability litigation.Close